Chronic Subcutaneous Octreotide Decreases Gastrointestinal Blood Loss in Blue Rubber–Bleb Nevus Syndrome

Abstract

Octreotide decreased the patient's need for blood transfusions. Possible mechanisms include altering blood flow to the gastrointestinal tract and direct effects on the venous malformations.